BCIM yields 3.77% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, BCIM + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCIM + JNJ for your $10,000?
BCIM is a passively managed, collateralized commodity investment. The fund generally tracks an index of four industrial metals futures (copper, aluminum, zinc, and nickel)combined with collaterals in an attempt to enhance returns. The underlying index includes futures contracts with maturities of 1 to 3 months, rolled according to a fixed schedule. At each annual rebalancing, these futures positions are weighted by liquidity and production data, subject to diversification rules. The fund manages its commodity exposure through a wholly owned Cayman Islands subsidiarya common structure in the commodity ETF space. On another note, its cash collaterals are invested mainly in 3-month US Treasuries whose returns are calculated using the most recent weekly auction high rate. BCIM comes on the back of BCI and BCD, and rounds out abrdn K-1 Free ETF trust.
Full BCIM Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.